Nia Therapeutics

medical devices

About

Nia Therapeutics is a neurotechnology company dedicated to developing an implanted neurostimulation therapy aimed at treating memory loss caused by traumatic brain injury (TBI) and other memory disorders. The company’s innovative approach features a personalized, closed-loop brain-computer interface (BCI) that monitors brain activity and delivers tailored electrical stimulation to enhance memory function when needed. Founded in 2018 by Dr. Michael Kahana and Dr. Daniel Rizzuto, Nia Therapeutics builds on research initially funded by the U.S. Department of Defense. Their flagship product continuously listens to brain signals and applies targeted stimulation during memory loss episodes. The therapy utilizes AI algorithms to personalize treatment based on individual brain data, with plans to expand its applications to neurodegenerative diseases and dementia. The company is also preparing for clinical trials to validate the safety and efficacy of its therapies, with enrollment expected to begin in 2026.

Technologies

Gmail Google Apps Google Cloud Hosting WordPress.org reCAPTCHA Mobile Friendly Android IoT Remote AI Data Analytics

Keywords

medical equipment manufacturing neural implant ai-driven therapy optimization biotechnology memory loss treatment medical devices neural sensing technology brain signal classification memory encoding detection brain network regulation services cloud ai system traumatic brain injury neurostimulation therapy brain-computer interface closed-loop stimulation brain activity patterns brain signals decoding ai-guided neurostimulation brain activity monitoring healthcare memory network rescue b2b personalized brain stimulation personalized neurostimulation electrical stimulation medical equipment and supplies manufacturing healthcare technology hospital & health care health care

Location

Boston, Massachusetts, United States, 02115

Related Companies

Companies in the same industry